Grant and Funding Programs Offered by Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)
Overview of Available Grants and Funding
Innovative Medicines Canada is a national pharmaceutical industry association that supports access to innovative medicines and vaccines across Canada. Its affiliated Health Research Foundation funds applied health research, awards, and scholarships. View Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)'s website for more information.
Content last updated: June 1, 2026
List of grants and funding offered by Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)
1 program available
- Maximum amount : 10,000 $
- Closes on July 1, 2026
- Canada
About Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)
What is the mission of Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)?
Innovative Medicines Canada says it partners to champion policies that drive the discovery, development, and delivery of transformative medicines and vaccines for Canadians. Its broader purpose is to support access to innovative treatments and strengthen the Canadian healthcare system.
What type of organization is Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)?
Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC) is a Industry association.
When was Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC) founded?
Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC) was founded in 1914-04-23.
What is Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)'s official website?
Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)'s official website is https://innovativemedicines.ca/.
What else should I know about Canada's Research-Based Pharmaceutical Companies (Rx&D) (IMC)?
Role of Innovative Medicines Canada in the funding ecosystem
Innovative Medicines Canada is the national association for Canada’s innovative pharmaceutical industry. The organization’s main role is advocacy and policy leadership, but its website also documents funding activity through its affiliated Health Research Foundation and scholarship partnerships.
Funding and support activities evidenced on the site
- The Health Research Foundation of Innovative Medicines Canada states that it funds applied research and recognizes research excellence.
- Site news includes award nominations such as the Diversity and Equity in Research Award, showing support for Canadian researchers.
- A joint announcement with Roche Canada created the Brigitte Nolet Scholarship for Indigenous pathways into life sciences at York University, including a $50,000 gift.
Organization profile and scope
The association represents member companies across Canada’s innovative medicines sector and works on access to medicines, pharmacare, rare disease policy, private drug coverage, and related health-system topics. It was founded in 1914 and adopted the name Innovative Medicines Canada in 2016.
Publics supported and overall impact
Through the Health Research Foundation, awards, and scholarship initiatives, the organization supports researchers, students, and academic health research while also advancing industry-wide health policy goals in Canada.